BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 1765976)

  • 21. Farmer's lung. Long-term outcome and lack of predictive value of bronchoalveolar lavage fibrosing factors.
    Lalancette M; Carrier G; Laviolette M; Ferland S; Rodrique J; Bégin R; Cantin A; Cormier Y
    Am Rev Respir Dis; 1993 Jul; 148(1):216-21. PubMed ID: 8317802
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HRCT in systemic sclerosis: correlation between respiratory functional indexes and extension of lung failure.
    Gatta G; Di Grezia G; Iacomino A; Russo A; Petrillo M; Feragalli B; Cappabianca S; Grassi R
    J Biol Regul Homeost Agents; 2013; 27(2):579-87. PubMed ID: 23830407
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [BALF from two different lung segments indicated by high resolution computer tomography (HRCT) in patients with sarcoidosis. III. Correlation between pulmonary function tests and HRCT changes and BAL cell count].
    Ziora D; Grzanka P; Niepsuj G; Mazur B; Oklek K
    Pneumonol Alergol Pol; 1999; 67(9-10):443-51. PubMed ID: 10808388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High resolution computed tomography in fibrosing alveolitis associated with systemic sclerosis.
    Launay D; Remy-Jardin M; Michon-Pasturel U; Mastora I; Hachulla E; Lambert M; Delannoy V; Queyrel V; Duhamel A; Matran R; De Groote P; Hatron PY
    J Rheumatol; 2006 Sep; 33(9):1789-801. PubMed ID: 16960939
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A longitudinal study of pulmonary involvement in primary Sjögren's syndrome: relationship between alveolitis and subsequent lung changes on high-resolution computed tomography.
    Salaffi F; Manganelli P; Carotti M; Baldelli S; Blasetti P; Subiaco S; Binci MC; Bichi Secchi E; Amici F; Cervini C
    Br J Rheumatol; 1998 Mar; 37(3):263-9. PubMed ID: 9566665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induced sputum as a tool for early detection of airway inflammation in connective diseases-related lung involvement.
    Vatrella A; Bocchino M; Perna F; Scarpa R; Galati D; Spina S; Pelaia G; Cazzola M; Sanduzzi A
    Respir Med; 2007 Jul; 101(7):1383-9. PubMed ID: 17369033
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bronchoalveolar lavage cellular profiles in patients with systemic sclerosis-associated interstitial lung disease are not predictive of disease progression.
    Goh NS; Veeraraghavan S; Desai SR; Cramer D; Hansell DM; Denton CP; Black CM; du Bois RM; Wells AU
    Arthritis Rheum; 2007 Jun; 56(6):2005-12. PubMed ID: 17530640
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HRCT and pulmonary function tests in monitoring of lung involvement in juvenile systemic sclerosis.
    Panigada S; Ravelli A; Silvestri M; Granata C; Magni-Manzoni S; Cerveri I; Dore R; Tomà P; Martini A; Rossi GA; Sacco O
    Pediatr Pulmonol; 2009 Dec; 44(12):1226-34. PubMed ID: 19911363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features.
    Colaci M; Sebastiani M; Manfredi A; Giuggioli D; Cassone G; Manzini CU; Ghizzoni C; Cerri S; Ferri C
    J Biol Regul Homeost Agents; 2014; 28(3):481-8. PubMed ID: 25316135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High-resolution chest CT in systemic lupus erythematosus.
    Fenlon HM; Doran M; Sant SM; Breatnach E
    AJR Am J Roentgenol; 1996 Feb; 166(2):301-7. PubMed ID: 8553934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage.
    Silver RM; Miller KS; Kinsella MB; Smith EA; Schabel SI
    Am J Med; 1990 May; 88(5):470-6. PubMed ID: 2337105
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biomarkers from bronchoalveolar lavage fluid in systemic sclerosis patients with interstitial lung disease relate to severity of lung fibrosis.
    Hesselstrand R; Wildt M; Bozovic G; Andersson-Sjöland A; Andréasson K; Scheja A; Westergren-Thorsson G; Bjermer L; Wuttge DM
    Respir Med; 2013 Jul; 107(7):1079-86. PubMed ID: 23660398
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A pilot study of intermittent intravenous cyclophosphamide for the treatment of systemic sclerosis associated lung disease.
    Várai G; Earle L; Jimenez SA; Steiner RM; Varga J
    J Rheumatol; 1998 Jul; 25(7):1325-9. PubMed ID: 9676764
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computed tomography-guided bronchoalveolar lavage in idiopathic pulmonary fibrosis.
    Agusti C; Xaubet A; Luburich P; Ayuso MC; Roca J; Rodriguez-Roisin R
    Thorax; 1996 Aug; 51(8):841-5. PubMed ID: 8795675
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Subclinical pulmonary involvement in collagen-vascular diseases assessed by bronchoalveolar lavage. Relationship between alveolitis and subsequent changes in lung function.
    Wallaert B; Hatron PY; Grosbois JM; Tonnel AB; Devulder B; Voisin C
    Am Rev Respir Dis; 1986 Apr; 133(4):574-80. PubMed ID: 3963625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interstitial lung disease in systemic sclerosis: a simple staging system.
    Goh NS; Desai SR; Veeraraghavan S; Hansell DM; Copley SJ; Maher TM; Corte TJ; Sander CR; Ratoff J; Devaraj A; Bozovic G; Denton CP; Black CM; du Bois RM; Wells AU
    Am J Respir Crit Care Med; 2008 Jun; 177(11):1248-54. PubMed ID: 18369202
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lung disease associated with progressive systemic sclerosis. Assessment of interlobar variation by bronchoalveolar lavage and comparison with noninvasive evaluation of disease activity.
    Miller KS; Smith EA; Kinsella M; Schabel SI; Silver RM
    Am Rev Respir Dis; 1990 Feb; 141(2):301-6. PubMed ID: 2301848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bronchoalveolar lavage fluid in scleroderma interstitial lung disease: technical aspects and clinical correlations: review of the literature.
    Kowal-Bielecka O; Kowal K; Highland KB; Silver RM
    Semin Arthritis Rheum; 2010 Aug; 40(1):73-88. PubMed ID: 19152959
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induced sputum in systemic sclerosis interstitial lung disease: comparison to healthy controls and bronchoalveolar lavage.
    Damjanov N; Ostojic P; Kaloudi O; Alari S; Guiducci S; Stanflin N; Nestorovic B; Knezevic J; Camiciottoli G; Porta F; Pistolesi M; Ibba-Manneschi L; Conforti ML; Candelieri A; Matucci Cerinic M
    Respiration; 2009; 78(1):56-62. PubMed ID: 18931474
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Interstitial lung disease in systemic sclerosis.
    Kaloudi O; Miniati I; Alari S; Matucci-Cerinic M
    Intern Emerg Med; 2007 Dec; 2(4):250-5. PubMed ID: 18172592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.